Monitoring of Breast Tissue Change Due to Hormone Replacement Therapy in Post-menopausal Women Using OBS (TiBS-HRT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00797199|
Recruitment Status : Completed
First Posted : November 25, 2008
Last Update Posted : March 23, 2016
|Condition or disease|
Show Detailed Description
|Study Type :||Observational|
|Actual Enrollment :||14 participants|
|Official Title:||Short-term Evaluations of Breast Tissue Change in Post-menopausal Women Using Optical Breast Spectroscopy (OBS)|
|Study Start Date :||September 2011|
|Actual Primary Completion Date :||December 2014|
|Actual Study Completion Date :||January 2015|
1-Treatment Group 1
Women receiving HRT treatment of Premarin.
2-Treatment Group 2
Women receiving combination HRT treatment of Premarin + Provera.
3- Treatment Group 3
Women receiving combination HRT treatment of Premarin + Prometrium.
Women not on HRT or healthy controls.
- Changes in OBS parameters [ Time Frame: 18 months ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00797199
|Princess Margaret Hospital|
|Toronto, Ontario, Canada, M5G 2M9|
|St. Michael's Hospital|
|Toronto, Ontario, Canada|
|Principal Investigator:||Lothar Lilge, PhD||Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada M5G 2M9; Department of Biophysics and Bioimaging, University of Toronto, Toronto, Ontario, Canada M5G 2M9|